These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37337010)

  • 21. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis.
    Xing Z; Tang L; Huang J; Peng X; Hu X
    BMJ Open; 2019 Mar; 9(3):e022509. PubMed ID: 30904835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragmented QRS predicts reperfusion failure and in-hospital mortality in ST-Elevation myocardial infarction: a systematic review and meta-analysis.
    Kewcharoen J; Trongtorsak A; Kittipibul V; Prasitlumkum N; Kanitsoraphan C; Putthapiban P; Mekraksakit P; Pattison RJ; Rattanawong P
    Acta Cardiol; 2020 Aug; 75(4):298-311. PubMed ID: 31021694
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.
    Fabris E; van 't Hof A; Hamm CW; Lapostolle F; Lassen JF; Goodman SG; Ten Berg JM; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Cantor WJ; Tsatsaris A; Kerneis M; Diallo A; Vicaut E; Montalescot G
    Eur Heart J Acute Cardiovasc Care; 2019 Apr; 8(3):208-217. PubMed ID: 28841028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    d'Entremont MA; Laferrière C; Bérubé S; Couture ÉL; Lepage S; Huynh T; Verreault-Julien L; Karzon A; Desgagnés N; Nguyen M
    Catheter Cardiovasc Interv; 2021 Mar; 97(4):591-599. PubMed ID: 32860646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction.
    Vogel RF; Delewi R; Angiolillo DJ; Wilschut JM; Lemmert ME; Diletti R; van Vliet R; van der Waarden NWPL; Nuis RJ; Paradies V; Alexopoulos D; Zijlstra F; Montalescot G; Krucoff MW; van Mieghem NM; Smits PC; Vlachojannis GJ
    JACC Cardiovasc Interv; 2021 Jun; 14(12):1323-1333. PubMed ID: 34167672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial infarction cardiogenic shock.
    Vallabhajosyula S; Verghese D; Bell MR; Murphree DH; Cheungpasitporn W; Miller PE; Dunlay SM; Prasad A; Sandhu GS; Gulati R; Singh M; Lerman A; Gersh BJ; Holmes DR; Barsness GW
    ESC Heart Fail; 2021 Jun; 8(3):2025-2035. PubMed ID: 33704924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editor's Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial.
    Karlsson S; Andell P; Mohammad MA; Koul S; Olivecrona GK; James SK; Fröbert O; Erlinge D
    Eur Heart J Acute Cardiovasc Care; 2019 Feb; 8(1):15-23. PubMed ID: 28862032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Yan Y; Wang X; Guo J; Li Y; Ai H; Gong W; Que B; Zhen L; Lu J; Ma C; Montalescot G; Nie S
    Am Heart J; 2020 Sep; 227():19-30. PubMed ID: 32663660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
    Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country.
    Chacón-Diaz M; Custodio-Sánchez P; Rojas De la Cuba P; Yábar-Galindo G; Rodríguez-Olivares R; Miranda-Noé D; López-Rojas LM; Hernández-Vásquez A
    BMC Cardiovasc Disord; 2022 Jun; 22(1):296. PubMed ID: 35768779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention.
    Moghaddam N; Wong GC; Cairns JA; Goodman SG; Perry-Arnesen M; Tocher W; Mackay M; Singer J; Lee T; Rao SV; Fordyce CB
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007175. PubMed ID: 30562086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Reperfusion Strategies in Patients with ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Trial.
    Khraishah H; Alahmad B; Secemsky E; Young MN; ElGuindy A; Siedner MJ; Kassab M; Kholte D; Khanbhai K; Janabi M; Kennedy K; Albaghdadi MS
    Glob Heart; 2020 Oct; 15(1):68. PubMed ID: 33150133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis.
    Tarantini G; D'Amico G; Brener SJ; Tellaroli P; Basile M; Schiavo A; Mojoli M; Fraccaro C; Marchese A; Musumeci G; Stone GW
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1765-76. PubMed ID: 27609250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI.
    Marbach JA; Almufleh A; Bernick J; Blondeau M; Osborne C; Russo J; Hibbert B; Froeschl M; Labinaz M; Glover C; Dick A; So D; Chong AY; Le May M
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):41-47. PubMed ID: 30269392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.